Remix Therapeutics (US)

https://www.remixtx.com

Twitter: @RemixThera

LinkedIn: https://www.linkedin.com/company/remix-therapeutics

Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Our REMaster technology platform allows us to identify patterns in RNA processing and exploit them to modulate gene expression. Our innovative therapeutic approach has the ability to alter the way genes are read from the genome, to correct, enhance, or eliminate the gene message, thereby addressing disease drivers at their origin. *

	Start	2020-12-08 existent
	Industry	RNA processing targeted therapeutics
	Industry 2	RNA processing reprogramming technology
	Person	Smith, Peter (Pete) (Remix Therapeutics 202012 CSO + Co-Founder)
	Person 2	Bitterman, Kevin (Atlas Venture 2017– Partner before Polaris Partners since 2004)

	Region	Cambridge, MA
	Country	United States (USA)
	Street	One Kendall Square Building 200
	City	02139 Cambridge, MA
		Address record changed: 2021-01-18

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Remix Therapeutics. (12/8/20). "Press Release: Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing". Cambridge, MA.

		Record changed: 2022-12-27